Esperion Therapeutics
ESPR • NASDAQ
Esperion Therapeutics is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Sheldon L. Koenig, with a market cap of $559.8M.
Market Cap$559.8M
Employees240.0
CEOSheldon L. Koenig
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Esperion Therapeutics FAQ
Common questions about Esperion Therapeutics
Esperion Therapeutics is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $90.8M.
Esperion Therapeutics has approximately 240 employees.